Candidate gene studies of a promising intermediate phenotype: failure to replicate.
- Authors
- Hart, Amy B; de Wit, Harriet; Palmer, Abraham A
- Year
- 2013
- Journal
- Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
- PMID
- 23303064
- DOI
- 10.1038/npp.2012.245
- PMCID
- PMC3671998
Many candidate gene studies use 'intermediate phenotypes' instead of disease diagnoses. It has been proposed that intermediate phenotypes have simpler genetic architectures such that individual alleles account for a larger percentage of trait variance. This implies that smaller samples can be used to identify genetic associations. Pharmacogenomic drug challenge studies may be an especially promising class of intermediate phenotype. We previously conducted a series of 12 candidate gene analyses of acute subjective and physiological responses to amphetamine in 99-162 healthy human volunteers (ADORA2A, SLC6A3, BDNF, SLC6A4, CSNK1E, SLC6A2, DRD2, FAAH, COMT, OPRM1). Here, we report our attempt to replicate these findings in over 200 additional participants ascertained using identical methodology. We were unable to replicate any of our previous findings. These results raise critical issues related to non-replication of candidate gene studies, such as power, sample size, multiple testing within and between studies, publication bias and the expectation that true allelic effect sizes are similar to those reported in genome-wide association studies. Many of these factors may have contributed to our failure to replicate our previous findings. Our results should instill caution in those considering similarly designed studies.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Cocaine-Induced Changes in the BRD4 Interactome Identifies Casein Kinase 1 Epsilon as a Therapeutic Target. | Seyednejad A et al. | β | 2026 | β |
| Large-scale behavioral characterization of oxycodone self-administration in heterogeneous stock rats reveals initial analgesic effects are associated with addiction-like behaviors. | Kallupi M et al. | β | 2026 | β |
| Genetic Associations of Persistent Opioid Use After Surgery Point to OPRM1 but Not Other Opioid-Related Loci as the Main Driver of Opioid Use Disorder. | Annis AC et al. | β | 2025 | β |
| Polymorphisms in the A118G SNP of the OPRM1 gene produce different experiences of opioids: A human laboratory phenotype-genotype assessment. | Dunn KE et al. | β | 2024 | β |
| Genotype-by-diagnosis interaction influences self-control in human cocaine addiction. | Graczyk MM et al. | β | 2023 | β |
| Trans-ancestry meta-analysis of genome wide association studies of inhibitory control. | Arnatkeviciute A et al. | β | 2023 | β |
| Individual differences in oxycodone addiction-like behaviors in a large cohort of heterogeneous stock (HS) rats | Kallupi M et al. | β | 2022 | β |
| The role of the SLC6A3 3' UTR VNTR in nicotine effects on cognitive, affective, and motor function. | SchrΓΆder R et al. | β | 2022 | β |
| Toward Precision Medicine in ADHD. | Buitelaar J et al. | β | 2022 | β |
| Individual Differences in Intertemporal Choice. | Keidel K et al. | β | 2021 | β |
| The Cocaine and Oxycodone Biobanks, Two Repositories from Genetically Diverse and Behaviorally Characterized Rats for the Study of Addiction. | Carrette LLG et al. | β | 2021 | β |
| Where the genome meets the connectome: Understanding how genes shape human brain connectivity. | Arnatkeviciute A et al. | β | 2021 | β |
| Steep Discounting of Future Rewards as an Impulsivity Phenotype: A Concise Review. | Levitt E et al. | β | 2020 | β |
| The Association of Aquaporin-1 Gene with Marathon Running Performance Level: a Confirmatory Study Conducted in Male Hispanic Marathon Runners. | Rivera MA et al. | β | 2020 | β |
| Genomic basis of delayed reward discounting. | Gray JC et al. | β | 2019 | β |
| Linking Delay Discounting and Substance Use Disorders: Genotypes and Phenotypes. | Mitchell SH | β | 2019 | β |
| The dopamine transporter VNTR polymorphism moderates the relationship between acute response to alcohol and future alcohol use disorder symptoms. | Schacht JP et al. | β | 2019 | β |
| Effects of Amphetamine on Sensorimotor Gating and Neurocognition in Antipsychotic-Medicated Schizophrenia Patients. | Swerdlow NR et al. | β | 2018 | β |
| Genetic analysis of impulsive personality traits: Examination of a priori candidates and genome-wide variation. | Gray JC et al. | β | 2018 | β |
| No major role of norepinephrine transporter gene variations in the cardiostimulant effects of MDMA. | Vizeli P et al. | β | 2018 | β |
| Self-reported Smoking Status, TAS2R38 Variants, and Propylthiouracil Phenotype: An Exploratory Crowdsourced Cohort Study. | Baker AN et al. | β | 2018 | β |
| The genetics of human personality. | Sanchez-Roige S et al. | β | 2018 | β |
| Weak effects of common genetic variation in oxytocin and vasopressin receptor genes on rhesus macaque social behavior. | Madlon-Kay S et al. | β | 2018 | β |
| A Spontaneous Mutation in <i>Taar1</i> Impacts Methamphetamine-Related Traits Exclusively in DBA/2 Mice from a Single Vendor. | Reed C et al. | β | 2017 | β |
| Casein kinase 1-epsilon deletion increases mu opioid receptor-dependent behaviors and binge eating1. | Goldberg LR et al. | β | 2017 | β |
| Genome-Wide Association Study of Loneliness Demonstrates a Role for Common Variation. | Gao J et al. | β | 2017 | β |
| Hierarchical investigation of genetic influences on response inhibition in healthy young adults. | Weafer J et al. | β | 2017 | β |
| The Role of Adenosine Receptors in Psychostimulant Addiction. | Ballesteros-YÑñez I et al. | β | 2017 | β |
| Association of the OPRM1 Variant rs1799971 (A118G) with Non-Specific Liability to Substance Dependence in a Collaborative de novo Meta-Analysis of European-Ancestry Cohorts. | Schwantes-An TH et al. | β | 2016 | β |
| COMT val158met moderation of dopaminergic drug effects on cognitive function: a critical review. | Schacht JP | β | 2016 | β |
| Dopamine pathway gene variants may modulate cognitive performance in the DHS - Mind Study. | Martelle SE et al. | β | 2016 | β |
| Experimental psychopathology paradigms for alcohol use disorders: Applications for translational research. | Bujarski S et al. | β | 2016 | β |
| Individual differences in timing of peak positive subjective responses to d-amphetamine: Relationship to pharmacokinetics and physiology. | Smith CT et al. | β | 2016 | β |
| Oxytocin receptor gene variation predicts subjective responses to MDMA. | Bershad AK et al. | β | 2016 | β |
| Pure and Confounded Effects of Causal SNPs on Longevity: Insights for Proper Interpretation of Research Findings in GWAS of Populations with Different Genetic Structures. | Yashin AI et al. | β | 2016 | β |
| Serotonin and Dopamine Gene Variation and Theory of Mind Decoding Accuracy in Major Depression: A Preliminary Investigation. | Zahavi AY et al. | β | 2016 | β |
| Single nucleotide polymorphism near CREB1, rs7591784, is associated with pretreatment methamphetamine use frequency and outcome of outpatient treatment for methamphetamine use disorder. | Heinzerling KG et al. | β | 2016 | β |
| Systems genetic and pharmacological analysis identifies candidate genes underlying mechanosensation in the von Frey test. | Young EE et al. | β | 2016 | β |
| 5-HTTLPR Genotype Moderates the Effects of Past Ecstasy Use on Verbal Memory Performance in Adolescent and Emerging Adults: A Pilot Study. | Wright NE et al. | β | 2015 | β |
| Adaptation of Subjective Responses to Alcohol is Affected by an Interaction of GABRA2 Genotype and Recent Drinking. | Kosobud AE et al. | β | 2015 | β |
| A review of pharmacogenetic studies of substance-related disorders. | Jones JD et al. | β | 2015 | β |
| Differences in subjective response to alcohol in heavy- and light-drinking Chinese men versus Caucasian American men. | Rueger SY et al. | β | 2015 | β |
| Genetics and brain morphology. | Strike LT et al. | β | 2015 | β |
| Genetic variation of the dopamine transporter (DAT1) influences the acute subjective responses to cocaine in volunteers with cocaine use disorders. | Brewer AJ et al. | β | 2015 | β |
| Multivariate analysis of subjective responses to d-amphetamine in healthy volunteers finds novel genetic pathway associations. | Yarosh HL et al. | β | 2015 | β |
| Quinine Bitterness and Grapefruit Liking Associate with Allelic Variants in TAS2R31. | Hayes JE et al. | β | 2015 | β |
| Specific and common genes implicated across major mental disorders: a review of meta-analysis studies. | Gatt JM et al. | β | 2015 | β |
| The pharmacogenetics of alcohol use disorder. | Jones JD et al. | β | 2015 | β |
| The Power of Theory, Research Design, and Transdisciplinary Integration in Moving Psychopathology Forward. | Vaidyanathan U et al. | β | 2015 | β |
| Association between the oxytocin receptor (OXTR) gene and mesolimbic responses to rewards. | Damiano CR et al. | β | 2014 | β |
| Dopamine transporter genotype and stimulant dose-response in youth with attention-deficit/hyperactivity disorder. | Stein MA et al. | β | 2014 | β |
| From genes to behavior: placing cognitive models in the context of biological pathways. | Saez I et al. | β | 2014 | β |
| MDMA effects consistent across laboratories. | Kirkpatrick MG et al. | β | 2014 | β |
| Social neuroscience and its potential contribution to psychiatry. | Cacioppo JT et al. | β | 2014 | β |
| A translational neuroscience framework for the development of socioemotional functioning in health and psychopathology. | Wiggins JL et al. | β | 2013 | β |
| Convergent effects of mouse Pet-1 deletion and human PET-1 variation on amygdala fear and threat processing. | Wellman CL et al. | β | 2013 | β |
| Does COMT genotype influence the effects of d-amphetamine on executive functioning? | Wardle MC et al. | β | 2013 | β |
| Genetic factors involved in risk for methamphetamine intake and sensitization. | Belknap JK et al. | β | 2013 | β |